ReviewCureus2025
A Meta-Analysis of the Impact of Mindfulness-Based Stress Reduction Therapy Intervention on Post-traumatic Stress Disorder.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This meta-analysis was conducted to investigate the effect of mindfulness-based stress reduction (MBSR) on the treatment and improvement of traumatic stress disorder (PTSD). Up until February 6, 2025, PubMed, Web of Science, and Embase databases were searched for randomized controlled trials of MBSR-based treatment for PTSD patients. RevMan 5.4 software (The Cochrane Collaboration, London, UK) was used to conduct a meta-analysis of these trials. A total of 832 participants from nine qualified randomized controlled trials were enrolled. Meta-analysis results showed that in PTSD patients, depression scores after Mindfulness-Based Stress Reduction (MBSR) intervention were significantly lower compared with the control group (Standardized Mean Difference (SMD) = -0.25, 95% CI -0.39 to -0.10; P = 0.0006). Quality of life (SMD = 0.40, 95% CI 0.10-0.70; P = 0.008) and Five Facet Mindfulness Questionnaire (SMD = 0.41, 95% CI 0.24-0.57; P < 0.00001) scores were significantly higher than in the control group. PTSD symptoms (SMD = -0.20, 95% CI -0.31 to -0.09; P = 0.0003), various PTSD checklist scores (SMD = -1.28, 95% CI -0.33 to -0.03; P = 0.02), and clinician-administered PTSD scale scores (SMD = -0.23, 95% CI -0.39 to -0.07; P = 0.004) were also significantly reduced following MBSR intervention. MBSR can reduce depression, PTSD symptoms, and improve the quality of life and mindfulness in PTSD patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.